Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Grupo Televisa SAB (ADR) - Level III | Alfonso de Angoitia Noriega | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 12,574,570 | 12,574,570 | - | - | CPOs held in Long-Term Retention Plan | |
| Grupo Televisa SAB (ADR) - Level III | Alfonso de Angoitia Noriega | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 12,066,300 | 12,066,300 | - | - | CPOs held in Long Term Retention Plan | |
| Rani Therapeutics Holdings Inc | Talat Imran | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 3,800,000 | 3,800,000 | - | - | Stock Option (Right to Buy) | |
| Abacus Life Inc (Class A) | Jay Jackson | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 2,000,000 | 2,000,000 | - | - | Performance Rights | |
| Minerva Neurosciences Inc | Remy Luthringer | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 1,690,700 | 1,690,700 | - | - | Employee Stock Option (right to buy) | |
| Quantinuum Inc Ordinary | Rajeeb Hazra | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 1,042,561 | 1,042,561 | - | - | Class A Common Stock | |
| Abacus Life Inc (Class A) | William H. McCauley | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 1,000,000 | 1,000,000 | - | - | Performance Rights | |
| Abacus Life Inc (Class A) | Elena Plesco | Chief Investment Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 1,000,000 | 1,000,000 | - | - | Performance Rights | |
| Abacus Life Inc (Class A) | Samantha Butcher | President of Life Solutions | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 1,000,000 | 1,000,000 | - | - | Performance Rights | |
| Rani Therapeutics Holdings Inc | Kate McKinley | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 805,500 | 805,500 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Alireza Javadi | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 805,500 | 805,500 | - | - | Stock Option (Right to Buy) | |
| Minerva Neurosciences Inc | Frederick W. Ahlholm | SVP, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 680,000 | 680,000 | - | - | Employee Stock Option (right to buy) | |
| Medicus Pharma Ltd | Syed Raza Bokhari | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Prudential PLC (ADR) | Anil Wadhwani | Executive Director,Chief Executive Officer | 03 Jun 2026 | 419,318 | 1,180,832 (0%) | 0% | 0 | Ords 0.05p | ||
| Surf Air Mobility Inc | Sudhin Shahani | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2026 | 408,163 | 74,020 | - | 0 | Common Stock | |
| Quantinuum Inc Ordinary | Rajeeb Hazra | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.00 per share. | 03 Jun 2026 | 336,389 | 706,172 | - | 60 | 20,183,340 | Class A Common Stock |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 03 Jun 2026 | 312,553 | 8,411,447 | - | 26.3 | 8,219,738 | Common Stock |
| Quantinuum Inc Ordinary | Nitesh Sharan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 289,798 | 289,798 | - | - | Class A Common Stock | |
| Rocket Lab USA Inc | Adam Spice | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 275,319 | 1,195,644 | - | 0 | Common Stock | |
| Grupo Televisa SAB (ADR) - Level III | Alfonso de Angoitia Noriega | Director, Co-Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 268,470 | 268,470 | - | - | CPOs held in Stock Purchase Plan | |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.19 per share. | 03 Jun 2026 | 250,000 | 445,600 | - | 0.2 | 47,500 | Common Shares |
| AbCellera Biologics Inc | Andrew Booth | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 250,000 | 8,501,849 | - | - | Share option (right to buy) | |
| Medicus Pharma Ltd | Carolyn Bonner | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | Faisal Mehmud | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 250,000 | 250,000 | - | - | Stock Option (right to buy) | |
| Aldeyra Therapeutics Inc | Todd C. Brady | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 03 Jun 2026 | 250,000 | 1,721,298 (6%) | 0% | 1.7 | 418,450 | Common Stock |
| Insperity Inc | Paul J. Sarvadi | Director, Chairman of the Board & CEO | Purchase of securities on an exchange or from another person at price $ 34.05 per share. | 03 Jun 2026 | 233,000 | 1,105,912 (2%) | 0% | 34.1 | 7,933,650 | Common Stock |
| Pacific Biosciences of California Inc | Kathy P. Ordonez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 223,492 | 223,492 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | Marshall L. Mohr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 223,492 | 223,492 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | Randall S. Livingston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 223,492 | 223,492 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | William W. Ericson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 223,492 | 223,492 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | John F. Milligan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 223,492 | 223,492 | - | - | Stock Option (right to buy) | |
| Pacific Biosciences of California Inc | Hannah A. Valantine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 223,492 | 223,492 | - | - | Stock Option (right to buy) | |
| MasterBrand Inc | R. David Banyard | Director, CEO & President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 206,826 | 2,038,614 | - | 0 | Common Stock, par value $0.01 per share | |
| Medicus Pharma Ltd | Andrew Smith | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Airship AI Holdings Inc (Class A) | Victor Huang | Director, CEO and Chairman of the BOD, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2026 | 200,000 | 3,832,207 | - | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 03 Jun 2026 | 200,000 | 8,424,000 | - | 3 | 600,000 | Common Stock |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 200,000 | 300,000 | - | - | Stock Options | |
| Microstrategy Inc (Class A) | Phong Q. Le | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 190,740 | 213,663 (2%) | 2% | 0 | Class A Common Stock | |
| Microstrategy Inc (Class A) | Phong Q. Le | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 190,740 | 0 | - | - | Performance Stock Unit | |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.16 per share. | 03 Jun 2026 | 168,626 | 8,242,821 | - | 27.2 | 4,580,169 | Common Stock |
| NPK Intl Inc | Matthew S. Lanigan | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 14.43 per share. | 03 Jun 2026 | 167,375 | 254,699 (0%) | 0% | 14.4 | 2,415,907 | Common Stock |
| Getty Images Holdings Inc (Class A) | Michael D. Teaster | Chief of Staff | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 151,898 | 526,962 | - | 0 | Class A Common Stock | |
| CSX | Kevin S. Boone | EVP & CFO | Sale of securities on an exchange or to another person at price $ 46.70 per share. | 03 Jun 2026 | 136,708 | 208,622 (0%) | 0% | 46.7 | 6,384,264 | Common Stock |
| MP Materials Corp | James H. Litinsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 68.65 per share. | 03 Jun 2026 | 136,141 | 11,620,798 | - | 68.7 | 9,346,080 | Common Stock |
| LENSAR Inc | Nicholas T. Curtis | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 130,662 | 1,122,758 | - | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 03 Jun 2026 | 125,021 | 8,298,979 | - | 26.3 | 3,287,890 | Common Stock |
| CSX | Kevin S. Boone | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.48 per share. | 03 Jun 2026 | 123,253 | 345,330 (0%) | 0% | 23.5 | 2,893,980 | Common Stock |
| CSX | Kevin S. Boone | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 123,253 | 123,254 | - | - | Option | |
| Offerpad Soln Inc (Class A) | Brian Bair | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 03 Jun 2026 | 122,920 | 307,454 | - | 0.8 | 97,402 | Class A Common Stock |
| Alignment Healthcare Inc | Joseph Konowiecki | Director, EVP, Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 122,807 | 1,203,816 | - | 0 | Common Stock | |
| Quantinuum Inc Ordinary | Rajeeb Hazra | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 122,791 | 122,791 | - | - | Stock Option | |
| Datadog Inc (Class A) | Dev C. Ittycheria | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 120,000 | 0 | - | - | Class B Common Stock | |
| Datadog Inc (Class A) | Dev C. Ittycheria | Director | 03 Jun 2026 | 120,000 | 0 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Dev C. Ittycheria | Director | 03 Jun 2026 | 120,000 | 159,235 (0%) | 0% | - | Class A Common Stock | ||
| Datadog Inc (Class A) | Dev C. Ittycheria | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 120,000 | 120,000 | - | - | Stock Option (Right to Buy) | |
| Quantinuum Inc Ordinary | Kevin Scott Dehoff | Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 111,460 | 111,460 | - | - | Class A Common Stock | |
| Unisys Corp | Troy K. Richardson | Director | Sale of securities on an exchange or to another person at price $ 4.40 per share. | 03 Jun 2026 | 110,000 | 106,451 (0%) | 0% | 4.4 | 484,374 | Common Stock |
| Offerpad Soln Inc (Class A) | Kenneth D. Degiorgio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 108,696 | 408,707 | - | 0 | Class A Common Stock | |
| Offerpad Soln Inc (Class A) | Ryan O’Hara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 108,696 | 328,849 | - | 0 | Class A Common Stock | |
| Offerpad Soln Inc (Class A) | Tela Gallagher Mathias | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 108,696 | 245,060 | - | 0 | Class A Common Stock | |
| Sportsman`s Warehouse Holdings Inc | Jennifer Fall Jung | CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 108,620 | 469,127 (1%) | 0% | 0 | Common Stock | |
| MasterBrand Inc | Andrea H. Simon | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 105,018 | 492,341 | - | 0 | Common Stock, par value $0.01 per share | |
| W & T Offshore Inc | John D. Buchanan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | John D. Buchanan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 177,340 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | Nancy T. Chang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 216,100 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | Nancy T. Chang | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Virginia Boulet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 547,597 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | Virginia Boulet | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | B. Frank Stanley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 497,073 (0%) | 0% | - | Common Stock | |
| W & T Offshore Inc | B. Frank Stanley | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Daniel O. Conwill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 0 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Daniel O. Conwill | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 103,448 | 251,076 (0%) | 0% | - | Common Stock | |
| Boyd Gaming Corp | Keith E. Smith | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 85.90 per share. | 03 Jun 2026 | 100,000 | 996,981 (0%) | 0% | 85.9 | 8,590,000 | Common Stock |
| Offerpad Soln Inc (Class A) | Brian Bair | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.74 per share. | 03 Jun 2026 | 91,167 | 1,763,237 | - | 0.7 | 67,464 | Class A Common Stock |
| Lexicon Pharma Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Raymond Debbane | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 1,995,498 (1%) | 0% | 0 | Common Stock | |
| Lexicon Pharma Inc | Samuel L. Barker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 213,771 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharma Inc | Samuel L. Barker | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Christopher J. Sobecki | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 293,177 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharma Inc | Philippe J. Amouyal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Philippe J. Amouyal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 374,486 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharma Inc | Judith L. Swain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 174,486 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharma Inc | Judith L. Swain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Diane E. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Diane E. Sullivan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 126,122 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharma Inc | Ivan H. Cheung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 0 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Ivan H. Cheung | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 89,312 | 89,312 (0%) | 0% | 0 | Common Stock | |
| Figma Inc Ordinary Shares | Praveer Melwani | CFO and Treasurer | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 03 Jun 2026 | 82,174 | 1,750,824 | - | 22.7 | 1,869,269 | Class A Common Stock |
| Fermi Inc | Mesut Uzman | Chief Nuclear Constr. Officer | Sale of securities on an exchange or to another person at price $ 6.31 per share. | 03 Jun 2026 | 79,509 | 670,491 | - | 6.3 | 501,702 | Common Stock |
| Fermi Inc | Mesut Uzman | Chief Nuclear Constr. Officer | Sale of securities on an exchange or to another person at price $ 6.31 per share. | 03 Jun 2026 | 79,032 | 670,968 | - | 6.3 | 498,692 | Common Stock |
| Quantinuum Inc Ordinary | Rajeeb Hazra | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 78,333 | 784,505 | - | 0 | Class A Common Stock | |
| Datadog Inc (Class A) | Dev C. Ittycheria | Director | Sale of securities on an exchange or to another person at price $ 248.54 per share. | 03 Jun 2026 | 76,981 | 81,768 (0%) | 0% | 248.5 | 19,132,711 | Class A Common Stock |
| Kestra Medical Tech Ltd | Brian Webster | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 75,681 | 410,467 | - | 0 | Common Shares | |
| Pacific Biosciences of California Inc | Christopher Gibson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 74,497 | 74,497 | - | - | Stock Option (right to buy) | |
| MasterBrand Inc | Navi Grewal | EVP, Chief Digital & Tech Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 72,929 | 286,842 | - | 0 | Common Stock, par value $0.01 per share | |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 71,167 | 151,422 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| MasterBrand Inc | Bruce A. Kendrick | EVP & Chief HR Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 70,012 | 267,910 | - | 0 | Common Stock, par value $0.01 per share | |
| Nano Nuclear Energy Inc | James Walker | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 03 Jun 2026 | 70,000 | 650,000 | - | 3 | 210,000 | Common Stock |
| Nano Nuclear Energy Inc | James Walker | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 70,000 | 430,000 | - | - | Stock Options | |
| Microstrategy Inc (Class A) | Andrew Kang | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 68,120 | 0 | - | - | Performance Stock Unit | |
| Microstrategy Inc (Class A) | Andrew Kang | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 68,120 | 101,795 (1%) | 0% | 0 | Class A Common Stock | |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.16 per share. | 03 Jun 2026 | 67,451 | 8,231,528 | - | 27.2 | 1,832,084 | Common Stock |
| Figma Inc Ordinary Shares | Shaunt Voskanian | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 03 Jun 2026 | 67,229 | 1,801,661 | - | 22.7 | 1,529,319 | Class A Common Stock |
| MasterBrand Inc | Andrean R. Horton | EVP, CLO & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 62,719 | 249,910 | - | 0 | Common Stock, par value $0.01 per share | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 03 Jun 2026 | 61,539 | 61,539 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 03 Jun 2026 | 61,539 | 5,236,691 | - | - | Class B Common Stock | ||
| Americas Car Mart Inc | Douglas W. Campbell | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 60,307 | 60,307 | - | - | Employee Stock Option (Right to Buy) | |
| ACM Research Inc (Class A) | David H. Wang | Director, See Remarks, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 03 Jun 2026 | 60,000 | 862,708 (5%) | 0% | 1 | 60,000 | Class A Common Stock |
| ACM Research Inc (Class A) | David H. Wang | Director, See Remarks, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 60,000 | 310,002 | - | - | Stock Option | |
| OneSpaWorld Holdings Ltd | Leonard I. Fluxman | Director, See Remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 24.07 per share. | 03 Jun 2026 | 57,051 | 1,167,191 (1%) | 0% | 24.1 | 1,373,218 | Common Shares |
| Atlas Lithium Corp | Marc Fogassa | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 4.28 per share. | 03 Jun 2026 | 55,555 | 5,102,503 | - | 4.3 | 237,792 | Common Stock |
| Claros Mortgage Trust Inc | W. Edward Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,418 | 53,418 | - | - | DEFERRED STOCK UNITS | |
| Claros Mortgage Trust Inc | Derrick D. Cephas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,418 | 53,418 | - | - | DEFERRED STOCK UNITS | |
| Claros Mortgage Trust Inc | Denise A. Olsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,418 | 53,418 | - | - | DEFERRED STOCK UNITS | |
| Claros Mortgage Trust Inc | Mary Haggerty | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,418 | 130,248 | - | 0 | COMMON STOCK | |
| Claros Mortgage Trust Inc | Steven L. Richman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,418 | 53,418 | - | - | DEFERRED STOCK UNITS | |
| Claros Mortgage Trust Inc | Pamela Liebman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,418 | 134,048 | - | 0 | COMMON STOCK | |
| Acumen Pharma Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,250 | 53,250 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | George Stanley Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,250 | 53,250 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Jeffrey L. Ives | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,250 | 53,250 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,250 | 53,250 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Sean Stalfort | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,250 | 53,250 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,250 | 53,250 | - | - | Stock Option (right to buy) | |
| Acumen Pharma Inc | Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 53,250 | 53,250 | - | - | Stock Option (right to buy) | |
| Hyperfine Inc (Class A) | Daniel J. Wolterman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 52,600 | 52,600 | - | - | Stock Options (right to buy) | |
| Medicus Pharma Ltd | Patrick J. Mahaffy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | William L. Ashton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | Barry Fishman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | Robert J. Ciaruffoli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | Larry Kaiser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | Sara R. May | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | Cathy McMorris Rodgers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Medicus Pharma Ltd | Ajay Raju | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Hans Peter Hasler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Jan van Heek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Fouzia Laghrissi-Thode | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Minerva Neurosciences Inc | David J. Kupfer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Minerva Neurosciences Inc | Inderjit Kaul | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Future FinTech Grp Inc | Ting Alina Ouyang | Director, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 50,000 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Future FinTech Grp Inc | Hu Li | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 50,000 | 57,500 (0%) | 0% | - | Common Stock, par value $0.001 per share | |
| Xometry Inc (Class A) | Lukas Biewald | Director | Purchase of securities on an exchange or from another person at price $ 85.00 per share. | 03 Jun 2026 | 47,058 | 55,134 | - | 85 | 3,999,930 | Class A Common Stock |
| Nano Nuclear Energy Inc | James Walker | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.18 per share. | 03 Jun 2026 | 46,145 | 603,855 | - | 26.2 | 1,208,030 | Common Stock |
| Orasure Tech Inc | Robert W. McMahon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 46,106 | 123,137 (0%) | 0% | 0 | Common Stock | |
| Orasure Tech Inc | Lelio Marmora | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 46,106 | 148,460 (0%) | 0% | 0 | Common Stock | |
| Orasure Tech Inc | Nancy J. Gagliano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 46,106 | 185,055 (0%) | 0% | 0 | Common Stock | |
| Orasure Tech Inc | Steven Kyle Boyd | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 46,106 | 159,568 (0%) | 0% | 0 | Common Stock | |
| Orasure Tech Inc | John D. Bertrand | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 46,106 | 79,767 (0%) | 0% | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 45,900 | 8,269,900 | - | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 45,900 | 275,778 | - | - | Restricted Stock Units | |
| HawkEye 360 Inc | Arthur L. Money | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 45,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| HawkEye 360 Inc | Arthur L. Money | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.31 per share. | 03 Jun 2026 | 45,000 | 54,545 | - | 2.3 | 103,950 | Common Stock |
| Quantinuum Inc Ordinary | Nitesh Sharan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 44,548 | 334,346 | - | 0 | Class A Common Stock | |
| Datadog Inc (Class A) | Dev C. Ittycheria | Director | Sale of securities on an exchange or to another person at price $ 249.22 per share. | 03 Jun 2026 | 42,533 | 39,235 (0%) | 0% | 249.2 | 10,600,198 | Class A Common Stock |
| e.l.f. Beauty Inc | Scott K. Milsten | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 42,315 | 157,255 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| e.l.f. Beauty Inc | Kory Marchisotto | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 42,315 | 194,732 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| e.l.f. Beauty Inc | Joshua Allen Franks | SVP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 42,315 | 160,386 (0%) | 0% | 0 | Common Stock, $0.01 par value | |
| ACM Research Inc (Class A) | David H. Wang | Director, See Remarks, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 03 Jun 2026 | 40,002 | 842,710 (5%) | 0% | 1 | 40,002 | Class A Common Stock |
| ACM Research Inc (Class A) | David H. Wang | Director, See Remarks, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 40,002 | 270,000 | - | - | Stock Option | |
| Comtech Telecom Corp | Jeffery Paul Robertson | President, Allerium Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 38,910 | 85,755 (0%) | 0% | - | Common Stock Par Value $0.10 Per Share | |
| Comtech Telecom Corp | Jeffery Paul Robertson | President, Allerium Segment | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 38,910 | 163,703 | - | - | Restricted Stock Units | |
| DENTSPLY Sirona Inc | Gregory T. Lucier | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2026 | 38,382 | 0 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Gregory T. Lucier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 38,382 | 38,382 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Gregory T. Lucier | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2026 | 38,382 | 63,283 (0%) | 0% | 0 | Common Stock | |
| Getty Images Holdings Inc (Class A) | Michael D. Teaster | Chief of Staff | Sale of securities on an exchange or to another person at price $ 0.79 per share. | 03 Jun 2026 | 38,100 | 488,862 | - | 0.8 | 30,099 | Class A Common Stock |
| LCI Ind | Jason D. Lippert | Director, President , CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jun 2026 | 38,033 | 0 | - | - | Performance Stock Unit | |
| MP Materials Corp | James H. Litinsky | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 70.23 per share. | 03 Jun 2026 | 37,286 | 11,756,939 | - | 70.2 | 2,618,596 | Common Stock |
| Federal Realty - REIT | Donald C. Wood | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2026 | 37,038 | 290,300 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Federal Realty - REIT | Donald C. Wood | Director, CEO & President | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2026 | 37,038 | 132,042 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| W & T Offshore Inc | John D. Buchanan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,972 | 35,972 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Nancy T. Chang | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,972 | 35,972 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Virginia Boulet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,972 | 35,972 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | B. Frank Stanley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,972 | 35,972 | - | - | Restricted Stock Units | |
| W & T Offshore Inc | Daniel O. Conwill | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,972 | 35,972 | - | - | Restricted Stock Units | |
| LegalZoom.com Inc | John F. Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,585 | 113,835 | - | 0 | Common Stock | |
| LegalZoom.com Inc | Sivan Whiteley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,585 | 131,965 | - | 0 | Common Stock | |
| LegalZoom.com Inc | Elizabeth Hamren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,585 | 125,665 | - | 0 | Common Stock | |
| LegalZoom.com Inc | Nathan Gooden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,585 | 112,736 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Kimberlee Cobleigh Drapkin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,500 | 48,300 | - | 0 | Common Stock | |
| Acumen Pharma Inc | George Stanley Golumbeski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,500 | 35,500 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Jeffrey L. Ives | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,500 | 48,300 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Derrell D. Porter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,500 | 48,300 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Sean Stalfort | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,500 | 220,624 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Nathan B. Fountain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,500 | 54,550 | - | 0 | Common Stock | |
| Acumen Pharma Inc | Laura Stoppel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,500 | 48,300 | - | 0 | Common Stock | |
| Trevi Therapeutics Inc | Anne M. Vanlent | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,000 | 35,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | David P. Meeker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,000 | 35,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Dominick C. Colangelo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,000 | 35,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Edward T. Mathers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,000 | 35,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| Trevi Therapeutics Inc | Michael T. Heffernan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 35,000 | 35,000 | - | - | Nonstatutory Stock Option (right to buy) | |
| GCI Liberty Inc - Ordinary Shares - Series A | Ronald A. Duncan | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 21.06 per share. | 03 Jun 2026 | 35,000 | 42,516 | - | 21.1 | 736,992 | Series C GCI Group Common Stock |
| LENSAR Inc | Alan B. Connaughton | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 34,843 | 389,173 | - | 0 | Common Stock | |
| Surgepays Inc | David May | Director | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 03 Jun 2026 | 34,716 | 156,626 | - | 0.5 | 18,243 | Common Stock |
| Xeris Biopharma Holdings Inc | Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 32,996 | 32,996 | - | - | Stock Option (Right to Buy) | |
| ACM Research Inc (Class A) | David H. Wang | Director, See Remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 89.84 per share. | 03 Jun 2026 | 32,450 | 819,663 (5%) | 0% | 89.8 | 2,915,308 | Class A Common Stock |
| TJX | Kenneth Canestrari | SEVP - Group President | Sale of securities on an exchange or to another person at price $ 157.50 per share. | 03 Jun 2026 | 31,447 | 107,781 (0%) | 0% | 157.5 | 4,952,814 | Common Stock |
| OneSpaWorld Holdings Ltd | Leonard I. Fluxman | Director, See Remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 24.03 per share. | 03 Jun 2026 | 31,431 | 1,224,242 (2%) | 0% | 24.0 | 755,287 | Common Shares |
| Cricut Inc (Class A) | Billie Ida Williamson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 30,414 | 112,478 | - | 0 | Class A Common Stock | |
| Cricut Inc (Class A) | Melissa Reiff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 30,414 | 112,478 | - | 0 | Class A Common Stock | |
| Cricut Inc (Class A) | Heidi Zak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 30,414 | 132,807 | - | 0 | Class A Common Stock | |
| Nano Nuclear Energy Inc | Jiang Yu | Director, President and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.29 per share. | 03 Jun 2026 | 30,250 | 8,239,650 | - | 26.3 | 795,273 | Common Stock |
| Home Bancshares Inc | John W. Allison | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2026 | 30,000 | 5,768,826 (3%) | 0% | 0 | Common Stock | |
| SiTime Corp | Rajesh Vashist | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 701.13 per share. | 03 Jun 2026 | 30,000 | 402,898 (2%) | 0% | 701.1 | 21,033,900 | Common Stock |
| Friedman Ind Inc | Michael J. Taylor | Director, President / CEO / Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 30,000 | 253,166 (3%) | 0% | 0 | Common Stock | |
| TJX | Ernie L. Herrman | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 157.46 per share. | 03 Jun 2026 | 29,549 | 552,850 (0%) | 0% | 157.5 | 4,652,679 | Common Stock |
| DENTSPLY Sirona Inc | Brian P. Mckeon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 28,887 | 28,887 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | James D. Forbes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 28,887 | 38,887 (0%) | 0% | 0 | Common Stock | |
| Nano Nuclear Energy Inc | James Walker | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 28,688 | 146,398 | - | - | Restricted Stock Units | |
| Nano Nuclear Energy Inc | James Walker | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 28,688 | 608,688 | - | 0 | Common Stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 112.09 per share. | 03 Jun 2026 | 28,339 | 18,676 | - | 112.1 | 3,176,411 | Class A Common Stock |
| TJX | Ernie L. Herrman | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 158.32 per share. | 03 Jun 2026 | 28,000 | 524,850 (0%) | 0% | 158.3 | 4,433,100 | Common Stock |
| Rocket Lab USA Inc | Agostino Ricupati | VP Corp Controller & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 27,532 | 27,532 | - | 0 | Common Stock | |
| Viasat Inc | Richard A. Baldridge | Director | Sale of securities on an exchange or to another person at price $ 71.74 per share. | 03 Jun 2026 | 27,122 | 213,355 (0%) | 0% | 71.7 | 1,945,732 | $.0001 par value common stock |
| NCR Voyix Corp | Kirk T. Larsen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 26,573 | 93,081 (0%) | 0% | 0 | Common Stock | |
| NCR Voyix Corp | Laura J. Sen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 26,573 | 92,872 (0%) | 0% | 0 | Common Stock | |
| NCR Voyix Corp | Janet Brutschea Haugen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 26,573 | 62,478 (0%) | 0% | 0 | Common Stock | |
| NCR Voyix Corp | Jeffrey S. Sloan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 26,573 | 44,541 (0%) | 0% | 0 | Common Stock | |
| NCR Voyix Corp | Kevin M. Reddy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 26,573 | 68,728 (0%) | 0% | 0 | Common Stock | |
| NCR Voyix Corp | Laura M. Miller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 26,573 | 62,478 (0%) | 0% | 0 | Common Stock | |
| NCR Voyix Corp | Irv Henderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 26,573 | 54,854 (0%) | 0% | 0 | Common Stock | |
| AVITA Medical Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 26,250 | 26,250 | - | - | Common Stock | |
| LCI Ind | Jason D. Lippert | Director, President , CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Jun 2026 | 26,066 | 0 | - | - | Performance Stock Unit | |
| Coherent Corp | James Robert Anderson | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 426.89 per share. | 03 Jun 2026 | 25,836 | 166,438 (0%) | 0% | 426.9 | 11,029,130 | Common Stock |
| Nano Nuclear Energy Inc | James Walker | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.77 per share. | 03 Jun 2026 | 25,792 | 582,896 | - | 26.8 | 690,426 | Common Stock |
| Kestra Medical Tech Ltd | Vaseem Mahboob | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 25,227 | 67,961 | - | 0 | Common Shares | |
| Kestra Medical Tech Ltd | Traci S. Umberger | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 25,227 | 161,860 | - | 0 | Common Shares | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 112.09 per share. | 03 Jun 2026 | 25,086 | 191,136 | - | 112.1 | 2,811,794 | Class A Common Stock |
| Medicus Pharma Ltd | Edward J. Brennan | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| GCI Liberty Inc - Ordinary Shares - Series A | Ronald A. Duncan | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 21.01 per share. | 03 Jun 2026 | 25,000 | 26,162 | - | 21.0 | 525,350 | Series C GCI Group Common Stock |
| Abercrombie & Fitch Co. (Class A) | Fran Horowitz-Bonadies | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 03 Jun 2026 | 25,000 | 492,793 (0%) | 0% | 0 | Class A Common Stock | |
| Nano Nuclear Energy Inc | James Walker | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 26.04 per share. | 03 Jun 2026 | 25,000 | 555,000 | - | 26.0 | 650,950 | Common Stock |
| Xeris Biopharma Holdings Inc | Marla S. Persky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 24,193 | 150,693 (0%) | 0% | 0 | Common Stock | |
| QuantumScape Corp (Class A) | Brad W. Buss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 24,183 | 146,659 | - | 0 | Class A Common Stock | |
| QuantumScape Corp (Class A) | Dennis Lynn Segers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 24,183 | 149,524 | - | 0 | Class A Common Stock | |
| QuantumScape Corp (Class A) | Geoffrey G. Ribar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 24,183 | 60,285 | - | 0 | Class A Common Stock | |
| QuantumScape Corp (Class A) | Jeneanne M. Hanley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 24,183 | 165,729 | - | 0 | Class A Common Stock | |
| QuantumScape Corp (Class A) | Gena C. Lovett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 24,183 | 144,354 | - | 0 | Class A Common Stock | |
| QuantumScape Corp (Class A) | Dipender Saluja | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 24,183 | 396,418 | - | 0 | Class A Common Stock | |
| QuantumScape Corp (Class A) | Ross S. Niebergall | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 24,183 | 71,558 | - | 0 | Class A Common Stock | |
| Keycorp | Elizabeth R. Gile | Director | Sale of securities on an exchange or to another person at price $ 20.88 per share. | 03 Jun 2026 | 23,946 | 21,255 (0%) | 0% | 20.9 | 499,992 | Common Shares |
| Rush Street Interactive Inc (Class A) | Kyle L. Sauers | Chief Financial Officer, President | Sale of securities on an exchange or to another person at price $ 25.44 per share. | 03 Jun 2026 | 23,000 | 631,258 | - | 25.4 | 585,120 | Class A Common Stock |
| TWFG Inc (Class A) | Michael Doak | Director | Purchase of securities on an exchange or from another person at price $ 18.62 per share. | 03 Jun 2026 | 22,994 | 746,722 | - | 18.6 | 428,148 | Class A Common Stock |
| Duluth Holdings Inc (Class B) | Ronald Robinson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,858 | 97,831 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | Susan J. Riley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,858 | 105,414 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | Scott K. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,858 | 164,942 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | David C. Finch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,858 | 230,338 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | Janet H. Kennedy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,858 | 139,531 (0%) | 0% | - | Class B Common Stock | |
| Duluth Holdings Inc (Class B) | Brett L. Paschke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,858 | 159,213 (0%) | 0% | - | Class B Common Stock | |
| Compass Inc (Class A) | Robert Reffkin | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 7.68 per share. | 03 Jun 2026 | 22,856 | 7,805,260 | - | 7.7 | 175,440 | Class A Common Stock |
| DENTSPLY Sirona Inc | Betsy D. Holden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,822 | 77,441 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Brian T. Gladden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,822 | 51,863 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Clyde R. Hosein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,822 | 64,075 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Donald J. Zurbay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,822 | 29,693 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Leslie F. Varon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,822 | 80,364 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Jonathan J. Mazelsky | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,822 | 51,668 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Janet S. Vergis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,822 | 67,324 (0%) | 0% | 0 | Common Stock | |
| DENTSPLY Sirona Inc | Michael J. Barber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,822 | 40,768 (0%) | 0% | 0 | Common Stock | |
| Nano Nuclear Energy Inc | James Walker | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 27.06 per share. | 03 Jun 2026 | 22,380 | 581,475 | - | 27.1 | 605,670 | Common Stock |
| AVITA Medical Inc | Jeremy L. Curnock Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,214 | 62,050 | - | - | Common Stock | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,214 | 108,985 | - | - | Common Stock | |
| AVITA Medical Inc | Jan Stern Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,214 | 73,225 | - | - | Common Stock | |
| AVITA Medical Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,214 | 48,464 | - | - | Common Stock | |
| AVITA Medical Inc | Suzanne Crowe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 22,214 | 69,148 | - | - | Common Stock | |
| Funko Inc (Class A) | Jesse Jacobs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 21,445 | 21,445 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Michael Kerns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 21,445 | 21,445 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Charles D. Denson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 21,445 | 21,445 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Trevor A. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 21,445 | 21,445 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Diane M. Irvine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 21,445 | 21,445 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Jason D. Harinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 21,445 | 21,445 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Sarah Kirshbaum Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 21,445 | 21,445 | - | - | Option to Purchase Class A Common Stock | |
| Funko Inc (Class A) | Reed Duchscher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 21,445 | 21,445 | - | - | Option to Purchase Class A Common Stock | |
| Precision Biosciences Inc | Geno J. Germano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 20,979 | 20,979 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Kevin J. Buehler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 20,979 | 20,979 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Melinda Brown | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 20,979 | 20,979 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Stanley R. Frankel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 20,979 | 20,979 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Shari Lisa Pire | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 20,979 | 20,979 | - | - | Restricted Stock Units | |
| SoundThinking Inc | Deborah Elam Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 20,361 | 49,001 (0%) | 0% | 0 | Common Stock | |
| Figma Inc Ordinary Shares | Shaunt Voskanian | Chief Revenue Officer | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 03 Jun 2026 | 20,281 | 1,781,380 | - | 23.9 | 484,430 | Class A Common Stock |
| Hewlett Packard | Gary M. Reiner | Director | Sale of securities on an exchange or to another person at price $ 54.77 per share. | 03 Jun 2026 | 20,000 | 82,941 (0%) | 0% | 54.8 | 1,095,384 | Common Stock |
| 908 Devices Inc | Christopher Brown | Director | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 03 Jun 2026 | 20,000 | 875,559 | - | 8.7 | 174,600 | Common Stock |
| Distribution Soln Grp Inc | Cesar A. Lanuza | President and CEO | Grant, award, or other acquisition of securities at price $ 27.47 per share. | 03 Jun 2026 | 20,000 | 100,498 (1%) | 0% | 27.5 | 549,400 | Common Stock |
| Nano Nuclear Energy Inc | Jaisun Garcha | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.00 per share. | 03 Jun 2026 | 20,000 | 365,000 | - | 3 | 60,000 | Common Stock |
| Nano Nuclear Energy Inc | Jaisun Garcha | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 20,000 | 150,000 | - | - | Stock Options | |
| Nano Nuclear Energy Inc | Jaisun Garcha | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.08 per share. | 03 Jun 2026 | 20,000 | 345,000 | - | 26.1 | 521,660 | Common Stock |
| ONE Gas Inc | John W. Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.47 per share. | 03 Jun 2026 | 19,976 | 292,670 (0%) | 0% | 77.5 | 1,547,541 | Common stock, par value $0.01 |
| ONE Gas Inc | John W. Gibson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 19,976 | 6,010 | - | - | Phantom Stock | |
| Comtech Telecom Corp | Jeffery Paul Robertson | President, Allerium Segment | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.64 per share. | 03 Jun 2026 | 19,798 | 65,957 (0%) | 0% | 5.6 | 111,661 | Common Stock Par Value $0.10 Per Share |
| Beam Therapeutics Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,676 | 19,676 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | John M. Maraganore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,676 | 19,676 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Mark C. Fishman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,676 | 19,676 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Kathleen E. Walsh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,676 | 19,676 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Christi Shaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,676 | 19,676 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Chirfi Guindo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,676 | 19,676 | - | - | Stock Option (Right to Buy) | |
| Kyndryl Holdings Inc | Martin J. Schroeter | Director, Chairman and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.25 per share. | 03 Jun 2026 | 19,407 | 2,449,086 | - | 12.3 | 237,736 | Common Stock |
| Denali Therapeutics Inc | Jay T. Flatley | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,226 | 19,226 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Peter S. Klein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,226 | 19,226 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | David P. Schenkein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,226 | 19,226 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Steven E. Krognes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,226 | 19,226 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Tim Van Hauwermeiren | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,226 | 19,226 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Jennifer E. Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,226 | 19,226 | - | - | Stock Option (right to buy) | |
| Denali Therapeutics Inc | Nancy A. Thornberry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,226 | 19,226 | - | - | Stock Option (right to buy) | |
| AVITA Medical Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,063 | 19,063 | - | - | Stock Options (Right to Buy) | |
| MasterBrand Inc | Andrew B. Cogan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 99,987 | - | 0 | Common Stock, par value $0.01 per share | |
| MasterBrand Inc | David D. Petratis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 58,328 | - | 0 | Common Stock, par value $0.01 per share | |
| MasterBrand Inc | Daniel T. Hendrix | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 99,009 | - | 0 | Common Stock, par value $0.01 per share | |
| MasterBrand Inc | Ann Fritz Hackett | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 77,413 | - | 0 | Common Stock, par value $0.01 per share | |
| MasterBrand Inc | Juliana L. Chugg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 65,317 | - | 0 | Common Stock, par value $0.01 per share | |
| MasterBrand Inc | Catherine Y. Courage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 40,357 | - | 0 | Common Stock, par value $0.01 per share | |
| MasterBrand Inc | Patrick S. Shannon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 41,672 | - | 0 | Common Stock, par value $0.01 per share | |
| MasterBrand Inc | Philip D. Fracassa | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 40,041 | - | 0 | Common Stock, par value $0.01 per share | |
| MasterBrand Inc | Robert C. Crisci | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 98,328 | - | 0 | Common Stock, par value $0.01 per share | |
| MasterBrand Inc | Jeffery S. Perry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,824 | 61,635 | - | 0 | Common Stock, par value $0.01 per share | |
| Americas Car Mart Inc | Jamie Z. Fischer | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,628 | 18,628 | - | - | Employee Stock Option (Right to Buy) | |
| Lyft Inc - Ordinary Shares Cls A | Prashant Aggarwal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,453 | 35,195 (0%) | 0% | 0 | Class A Common Stock | |
| Lyft Inc - Ordinary Shares Cls A | David Lawee | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,453 | 123,737 (0%) | 0% | 0 | Class A Common Stock | |
| Lyft Inc - Ordinary Shares Cls A | Deborah A. P. Hersman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,453 | 23,295 (0%) | 0% | 0 | Class A Common Stock | |
| Lyft Inc - Ordinary Shares Cls A | David E. Stephenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,453 | 106,064 (0%) | 0% | 0 | Class A Common Stock | |
| Lyft Inc - Ordinary Shares Cls A | Janey Whiteside | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,453 | 79,537 (0%) | 0% | 0 | Class A Common Stock | |
| Lyft Inc - Ordinary Shares Cls A | Betsey Stevenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,453 | 68,903 (0%) | 0% | 0 | Class A Common Stock | |
| Lyft Inc - Ordinary Shares Cls A | Jill Beggs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,453 | 48,545 (0%) | 0% | 0 | Class A Common Stock | |
| SoundThinking Inc | Burton M. Goldfield | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,180 | 27,422 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | William J. Bratton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,180 | 62,445 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | Marc H. Morial | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,180 | 63,057 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | Roberta S. Jacobson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,180 | 47,469 (0%) | 0% | 0 | Common Stock | |
| SoundThinking Inc | Ruby Sharma | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 18,180 | 47,056 (0%) | 0% | 0 | Common Stock | |
| Stoke Therapeutics Inc | Arthur A. Levin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,786 | 17,786 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Seth L. Harrison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,786 | 17,786 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Edward M. Kaye | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,786 | 17,786 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Julie Anne Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,786 | 17,786 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Arthur O. Tzianabos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,786 | 17,786 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Jennifer C. Burstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,786 | 17,786 | - | - | Director Stock Option (Right to Buy) | |
| Stoke Therapeutics Inc | Adrian R. Krainer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,786 | 17,786 | - | - | Director Stock Option (Right to Buy) | |
| Outset Medical Inc | Renee M. Gaeta | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.94 per share. | 03 Jun 2026 | 17,672 | 113,753 | - | 4.9 | 87,300 | Common Stock |
| ACM Research Inc (Class A) | David H. Wang | Director, See Remarks, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 85.11 per share. | 03 Jun 2026 | 17,543 | 823,107 (5%) | 0% | 85.1 | 1,493,085 | Class A Common Stock |
| LENSAR Inc | Aimee S. Weisner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,421 | 110,368 | - | 0 | Common Stock | |
| LENSAR Inc | William J. Link | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,421 | 568,062 | - | 0 | Common Stock | |
| LENSAR Inc | Richard L. Lindstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,421 | 263,831 | - | 0 | Common Stock | |
| LENSAR Inc | Elizabeth G. O’Farrell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,421 | 67,368 | - | 0 | Common Stock | |
| LENSAR Inc | Gary M. Winer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,421 | 105,635 | - | 0 | Common Stock | |
| LENSAR Inc | Thomas B. Ellis | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,421 | 56,083 | - | 0 | Common Stock | |
| LENSAR Inc | Todd B. Hammer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 17,421 | 56,083 | - | 0 | Common Stock | |
| Nano Nuclear Energy Inc | Jaisun Garcha | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 17,215 | 87,845 | - | - | Restricted Stock Units | |
| Nano Nuclear Energy Inc | Jaisun Garcha | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 17,215 | 362,215 | - | 0 | Common Stock | |
| Viasat Inc | Richard A. Baldridge | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 17,122 | 0 | - | - | employee stock option (right to buy) | |
| Viasat Inc | Richard A. Baldridge | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.43 per share. | 03 Jun 2026 | 17,122 | 230,477 (0%) | 0% | 53.4 | 914,828 | $.0001 par value common stock |
| NovoCure Ltd | Gabriel Leung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,999 | 16,999 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Timothy John Scannell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,999 | 16,999 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | David T. Hung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,999 | 16,999 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Jeryl L. Hilleman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,999 | 16,999 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | W. Anthony Vernon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,999 | 16,999 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Martin J. Madden | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,999 | 16,999 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Kristin Stafford | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,999 | 16,999 | - | - | Stock Option (Right to Buy) | |
| NovoCure Ltd | Allyson J. Ocean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,999 | 16,999 | - | - | Stock Option (Right to Buy) | |
| Americas Car Mart Inc | Jonathan Collins | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,687 | 16,687 | - | - | Employee Stock Option (Right to Buy) | |
| LCI Ind | John A. Sirpilla | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,503 | 16,503 | - | - | Restricted Stock Unit | |
| Hanover Insurance Grp Inc | Bryan J. Salvatore | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 16,394 | 0 | - | - | Common Stock Option (right to buy) | |
| Hanover Insurance Grp Inc | Bryan J. Salvatore | Executive Vice President | Sale of securities on an exchange or to another person at price $ 185.76 per share. | 03 Jun 2026 | 16,394 | 29,069 (0%) | 0% | 185.8 | 3,045,349 | Common Stock |
| Hanover Insurance Grp Inc | Bryan J. Salvatore | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 104.11 per share. | 03 Jun 2026 | 16,394 | 45,463 (0%) | 0% | 104.1 | 1,706,779 | Common Stock |
| Microstrategy Inc (Class A) | Phong Q. Le | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 119.53 per share. | 03 Jun 2026 | 16,303 | 139,996 (1%) | 0% | 119.5 | 1,948,681 | Class A Common Stock |
| Teva- pharma Ind Ltd (ADR) | Matthew Shields | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 16,195 | 26,184 (0%) | 0% | - | Ordinary Shares | |
| Teva- pharma Ind Ltd (ADR) | Matthew Shields | EVP, Global Operations | Sale of securities on an exchange or to another person at price $ 32.87 per share. | 03 Jun 2026 | 16,195 | 9,989 (0%) | 0% | 32.9 | 532,330 | Ordinary Shares |
| Teva- pharma Ind Ltd (ADR) | Matthew Shields | EVP, Global Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 16,195 | 32,392 | - | - | Restricted Share Units | |
| AVITA Medical Inc | Jeremy L. Curnock Cook | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,133 | 16,133 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Robert E. Mcnamara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,133 | 16,133 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Jan Stern Reed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,133 | 16,133 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Michael E. Tarnoff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,133 | 16,133 | - | - | Stock Options (Right to Buy) | |
| AVITA Medical Inc | Suzanne Crowe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 16,133 | 16,133 | - | - | Stock Options (Right to Buy) | |
| Microstrategy Inc (Class A) | Phong Q. Le | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 118.59 per share. | 03 Jun 2026 | 15,954 | 156,299 (1%) | 0% | 118.6 | 1,892,017 | Class A Common Stock |
| Microstrategy Inc (Class A) | Phong Q. Le | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 117.53 per share. | 03 Jun 2026 | 15,892 | 172,253 (2%) | 0% | 117.5 | 1,867,803 | Class A Common Stock |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.94 per share. | 03 Jun 2026 | 15,829 | 135,593 (0%) | 0% | 51.9 | 822,158 | Common Stock, $0.01 par value |
| e.l.f. Beauty Inc | Tarang P. Amin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 51.94 per share. | 03 Jun 2026 | 15,829 | 135,593 (0%) | 0% | 51.9 | 822,158 | Common Stock, $0.01 par value |
| NVIDIA | Stephen C. Neal | Director | Sale of securities on an exchange or to another person at price $ 215.73 per share. | 03 Jun 2026 | 15,500 | 116,135 (0%) | 0% | 215.7 | 3,343,863 | Common Stock |
| Xeris Biopharma Holdings Inc | Marla S. Persky | Director | Sale of securities on an exchange or to another person at price $ 5.90 per share. | 03 Jun 2026 | 15,500 | 126,500 (0%) | 0% | 5.9 | 91,433 | Common Stock |
| Figs Inc (Class A) | Jeffrey A. Wilke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,456 | 227,577 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | Melanie Whelan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,456 | 55,683 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | Mario J. Marte | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,456 | 86,046 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | Sheila Antrum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,456 | 115,663 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | John Martin Willhite | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,456 | 3,263,095 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | Kenneth Lin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,456 | 161,705 | - | 0 | Class A Common Stock | |
| Figs Inc (Class A) | Jerry Jao | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,456 | 97,719 | - | 0 | Class A Common Stock | |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 03 Jun 2026 | 15,385 | 15,385 | - | - | Class A Common Stock | ||
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | 03 Jun 2026 | 15,385 | 2,932,535 | - | - | Class B Common Stock | ||
| Nano Nuclear Energy Inc | Jaisun Garcha | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 26.84 per share. | 03 Jun 2026 | 15,223 | 346,992 | - | 26.8 | 408,646 | Common Stock |
| Inhibrx Biosciences Inc | Kimberly J. Manhard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Inhibrx Biosciences Inc | Jon Faiz Kayyem | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Inhibrx Biosciences Inc | Kristiina Vuori | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Quantinuum Inc Ordinary | Kevin Scott Dehoff | Chief Strategy Officer | Purchase of securities on an exchange or from another person at price $ 60.00 per share. | 03 Jun 2026 | 15,000 | 126,460 | - | 60 | 900,000 | Class A Common Stock |
| Friedman Ind Inc | Gaurav Chhibbar | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 15,000 | 66,400 (0%) | 0% | 0 | Common Stock | |
| Open Lending Corp | Abhijit Chaudhary | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 14,943 | 0 | - | - | Restricted Stock Units | |
| Open Lending Corp | Abhijit Chaudhary | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2026 | 14,943 | 14,943 | - | 0 | Common Stock, par value $0.01 per share | |
| Ocular Therapeutix Inc | Nadia Waheed | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 8.27 per share. | 03 Jun 2026 | 14,828 | 300,079 (0%) | 0% | 8.3 | 122,628 | Common Stock |
| CoreWeave Inc (Class A) | Brian Venturo | Director, Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 111.12 per share. | 03 Jun 2026 | 14,524 | 47,015 | - | 111.1 | 1,613,869 | Class A Common Stock |
| Funko Inc (Class A) | Jesse Jacobs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 14,368 | 14,368 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Michael Kerns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 14,368 | 14,368 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Charles D. Denson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 14,368 | 14,368 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Trevor A. Edwards | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 14,368 | 14,368 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Diane M. Irvine | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 14,368 | 14,368 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Jason D. Harinstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 14,368 | 14,368 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Sarah Kirshbaum Levy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 14,368 | 14,368 | - | - | Restricted Stock Units | |
| Funko Inc (Class A) | Reed Duchscher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 14,368 | 14,368 | - | - | Restricted Stock Units |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.